Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Iron accumulation has been reported to be associated with progression of liver injury. The mechanism of iron accumulation in the liver is not known. In the present study, hepatic messenger RNA (mRNA) expression of transferrin receptor (TfR)1, TfR2, and ferroportin (FP)1 was measured in patients with chronic hepatitis (CH). Methods: Eleven patients with CH‐B and 43 patients with CH‐C were enrolled. All patients underwent liver biopsy. Hepatic expression of TfR1, TfR2 and FP1 mRNA was analyzed using a real‐time polymerase chain reaction. Total hepatic iron score (THIS) was evaluated by Prussian blue staining. Results: Serum ferritin concentration is significantly higher in CH‐C than in CH‐B. Values of THIS of ≥5 were observed only in CH‐C patients (44% of CH‐C patients). The expression level of TfR2 mRNA was 10–26‐fold higher than the TfR1 mRNA expression level. The TfR2 and FP1 mRNA expression was significantly higher in CH‐C than in CH‐B patients. Hepatic expression of TfR2 and FP1 mRNA was well correlated with THIS. Conclusions: Hepatic iron accumulation is more severe in patients with CH‐C. Upregulation of hepatic iron transporters may contribute to the hepatic iron accumulation in CH‐C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Regulating the fate of mRNA: the control of cellular iron metabolism
Klausner, R. D., Rouault, T. A., & Harford, J. B. (1993) · Cell · doi:10.1016/0092-8674(93)90046-s · Cited by 1,210
Hepatitis C, iron status, and disease severity: Relationship with HFE mutations
Tung, B. Y., Emond, M. J., Bronner, M. P., Raaka, S. D., Cotler, S. J., & Kowdley, K. V. (2003) · Gastroenterology · doi:10.1053/gast.2003.50046 · Cited by 154
Cited by
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C
Fujita, N., Sugimoto, R., Takeo, M., Urawa, N., Mifuji, R., Tanaka, H., Kobayashi, Y., Iwasa, M., Watanabe, S., Adachi, Y., et al. (2007) · Molecular Medicine · doi:10.2119/2006-00057.fujita · Cited by 211
“We previously reported that transferrin receptor 2 (TfR2), which was recently identified as the second receptor for transferrin (15), was higher in the liver of patients with chronic hepatitis C compared than those with chronic hepatitis B (16).”
BackgroundSelf-citationReview article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
Metadata
- Authors
- TAKEO, M., KOBAYASHI, Y., FUJITA, N., URAWA, N., IWASA, M., HORIIKE, S., TANAKA, H., KAITO, M., & ADACHI, Y.
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2005-02-23
- Volume
- 20
- Issue
- 4
- Pages
- 562-569
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W1977898965
- Cited by
- 34
- References
- 3
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. https://app.cochat.ai/papers/10.1111/j.1440-1746.2005.03770.x
- The paper
- TAKEO, M., KOBAYASHI, Y., FUJITA, N., URAWA, N., IWASA, M., HORIIKE, S., TANAKA, H., KAITO, M., & ADACHI, Y. (2005). Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2005.03770.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.